ArticleCell death & disease2024

PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway.

Yuanzhen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.